Ensysce Biosciences, Inc.
ENSC
$2.17
-$0.30-12.15%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.56M | 661.80K | -1.97M | -3.12M | -3.50M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | 0.00 | 0.00 | 25.70K | 1.17M | 326.20K |
| Total Other Non-Cash Items | 47.80K | 18.50K | 20.60K | 51.50K | 633.40K |
| Change in Net Operating Assets | 2.75M | -1.70M | -388.40K | -1.51M | 742.00K |
| Cash from Operations | -764.10K | -1.02M | -2.31M | -3.41M | -1.80M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | 1.61M |
| Total Debt Repaid | -96.30K | -71.40K | -51.20K | -638.90K | -144.50K |
| Issuance of Common Stock | 357.90K | 1.67M | 0.00 | 2.08M | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -149.00K | 2.53M | 0.00 | 4.25M | 0.00 |
| Cash from Financing | 112.60K | 4.13M | -51.20K | 5.69M | 1.46M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -651.50K | 3.11M | -2.36M | 2.28M | -340.80K |